Nodoryl (Metamizole Sodium Monohydrate)

Metamizole Sodium works by non‑selectively inhibiting cyclooxygenase enzymes (COX‑1 and COX‑2), which reduces the synthesis of prostaglandins. Lower prostaglandin levels diminish pain signaling, lower fever, and produce a central spasmolytic effect, providing analgesia without engaging opioid pathways.

The specific dose of Nodoryl is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and clinical response. Dosage recommendations are provided in the product’s prescribing information and must be followed as directed by a qualified prescriber.

Safety data for Metamizole Sodium in pregnancy and lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by the prescriber. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To order Nodoryl, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nodoryl (Metamizole Sodium) belongs to the pyrazolone class, offering analgesic, antipyretic, and spasmolytic effects. Unlike paracetamol, it has a stronger anti‑spasmodic action, and compared with ibuprofen, it may have a lower risk of gastrointestinal irritation but carries a rare risk of severe blood dyscrasias. Choice depends on the clinical scenario and patient risk profile.

Nodoryl should be stored at room temperature, below 25 °C, in its original packaging. It must be protected from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Nodoryl is administered orally, typically as a tablet or oral solution, according to the prescriber’s instructions. The medication should be taken with a full glass of water and may be taken with or without food, depending on the individual’s tolerance and the prescriber’s guidance.

The most serious risks include agranulocytosis, a potentially life‑threatening reduction in white blood cells, and severe skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored for signs of infection, rash, or unusual bleeding, and any concerning symptoms should prompt immediate medical evaluation.

Nodoryl should be avoided in patients with a known hypersensitivity to Metamizole or other pyrazolones, those with a history of agranulocytosis or severe leukopenia, and individuals receiving concurrent cytotoxic chemotherapy without close monitoring. It is also contraindicated in patients with severe liver or kidney impairment unless specifically directed by a physician.